Monthly Archives: January 2012

Modest Increase in Mesothelioma Survival from Chemotherapy

The chemotherapy combination that has become the standard of care for mesothelioma in many parts of the world appears to be making a modest but measurable difference for mesothelioma patients in The Netherlands. Mesothelioma is caused almost exclusively by inhalation … Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , , , , , | Leave a comment

Vatalanib Not Effective as a ‘Single Agent’ for Mesothelioma

There has been a setback for doctors hoping the drug vatalanib would be a viable alternative to chemotherapy for mesothelioma patients. Scientists with the Cancer and Leukemia Group B (CALGB), a research team based at the University of California, have … Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , , | Leave a comment

National Cancer Institute Opening Two New Trials For Mesothelioma Patients

The steps often have been slow, but Dr. Raffit Hassan in Bethesda, Maryland, keeps plugging away in the search for better options to treat malignant mesothelioma. He never has been more optimistic. Hassan, a senior investigator at the National Cancer … Continue reading

Posted in National Asbestos | Tagged , , , , , , , , , , , | Leave a comment

Brighton base for new centre at forefront of cancer research

A major centre which will carry out groundbreaking trials of the latest treatment for critically ill cancer patients is to be based in Brighton. Experts say the Experimental Cancer Medical Centre will benefit patients in Sussex and put Brighton at … Continue reading

Posted in National Asbestos | Tagged , | Leave a comment